|
gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:ramipril
|
|
gptkbp:approvedBy
|
1991
|
|
gptkbp:ATCCode
|
C09AA05
|
|
gptkbp:bioavailability
|
28%
|
|
gptkbp:CASNumber
|
87333-19-5
|
|
gptkbp:chemicalFormula
|
C23H32N2O5
|
|
gptkbp:contraindication
|
pregnancy
bilateral renal artery stenosis
history of angioedema
|
|
gptkbp:drugClass
|
gptkb:ACE_inhibitor
|
|
gptkbp:eliminationHalfLife
|
13-17 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:KEGGID
|
D08602
|
|
gptkbp:legalStatus
|
Rx-only
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:MedlinePlusID
|
a692027
|
|
gptkbp:MeSH_ID
|
D016123
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:pregnancyWarning
|
can cause injury and death to the developing fetus
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:proteinBinding
|
73%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1428
5464096
DB00178
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
cough
hypotension
hyperkalemia
|
|
gptkbp:status
|
FDA approved
|
|
gptkbp:UNII
|
497Y77246T
|
|
gptkbp:usedFor
|
heart failure
hypertension
reduction of cardiovascular risk
|
|
gptkbp:bfsParent
|
gptkb:King_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Altace
|